As the GLP-1 drugs started getting more and more popular, I decided to perform some due diligence and refresh what I had learned in med school about this thing called glucagon-like peptide. These drugs bind to the same receptor that GLP does, primarily to cause the pancreas to release more insulin when blood sugar is high
If something doesn't feel right, we won't proceed - your safety always comes first
These benefits appear to reflect both improvements in traditional risk factors - weight, blood pressure, lipid profiles, glycemic control - and potentially direct cardioprotective effects mediated by GLP-1 receptors expressed in cardiomyocytes and vascular endothelium
They matter if they interfere with eating, sleeping, mood, work, school, or driving